助手标题  
全文文献 工具书 数字 学术定义 翻译助手 学术趋势 更多
查询帮助
意见反馈
   抗病毒治疗后 的翻译结果: 查询用时:0.495秒
图标索引 在分类学科中查询
所有学科
感染性疾病及传染病
消化系统疾病
更多类别查询

图标索引 历史查询
 

抗病毒治疗后
相关语句
  antiviral therapy
     Results: The levels of IL-2, IFN-γ, IL-4, IL-10 in the serums changed after the antiviral therapy, in which the levels of IL-2, IFN-γ increased and the levels of IL-4, IL-10 decreased gradually.
     结果:抗病毒治疗后 IL- 2、IFN- γ、IL- 4、IL- 10水平发生了明显变化。
短句来源
     Results: The levels of IL-2, IFN- γ , IL-4, IL-10 in the serums changed after the antiviral therapy.
     结果:抗病毒治疗后IL-2、IFN-γ、IL-4、IL-10发生了明显的变化。
短句来源
     CMV antigenemia became negative on average day 24. 6 ±11. 3, and the average duration of antiviral therapy was(34. 2 ±7. 1 ) days.
     42例CMV-PP65抗原血症阳性受者抗病毒治疗后抗原血症均阴转,1例发展为CMV病,平均阴转时间为(24. 6±11. 3) d,平均疗程为(34. 2±7.1) d。
短句来源
     There were 25 cases who positively responded to antiviral therapy (effective ratio 86.21%) and 4 cases died (case-fatality ratio 13.79%).
     29例经抗病毒治疗后25例抗原转为阴性,有效率86.21%,死亡4例,病死率13.79%。
短句来源
     An evaluation on quality of life in patients with chronic hepatitis B after antiviral therapy: health questionnaire survey
     慢性乙型肝炎患者抗病毒治疗后生存质量评估
短句来源
更多       
  “抗病毒治疗后”译为未确定词的双语例句
     [Objection] To study the level changing of T cell subgroup Th1/Th2 cytokine and the relation of cytokine changing with liver function ALT and serum HBVDNA tite in the chronic hepatitis B patients accepted INFα-2a therapy.
     目的探讨慢性乙肝患者接受干扰素α-2a(INFα-2a)抗病毒治疗后血清T淋巴细胞亚群Th1/Th2细胞因子水平的变化及与肝功能ALT恢复、血清HBVDNA含量变化的关系。
短句来源
     After antiviral treatment for 6 months, lamivudine seemed to induce the increase of frequency and absolute number of pDC2. The absolute numbers of peripheral CD8~+ T-cells and NK cells were simultaneously found to ascend.
     抗病毒治疗后,拉米夫定组pDC2的比例和数量有提高,伴随自然杀伤(NK)细胞及CD8+T细胞数量的提高;
短句来源
     AIM: To study the relationship between the changes of tumor necrosis factor α (TNF α) and interleukin 8 (IL 8) level in serum of patients with chronic hepatitis B (CHB) before and after interferon α (IFN α) treatment and expression of hepatitis B virus (HBV) marker.
     目的 :观察慢性乙型肝炎患者经α 干扰素 (IFN α)抗病毒治疗后血清中肿瘤坏死因子 α(TNF α)和白细胞介素 8(IL 8)水平的变化与乙型肝炎病毒消长之间的关系。
短句来源
     Study on the immune reconstitution in 20 AIDS patients under highly active antiretroviral therapy
     20例艾滋病病人经高效联合抗病毒治疗后免疫重建研究
短句来源
     [Conclusion] T cell subgroup cytokine was related with the normal ALT and the descent HBVDNA tites after the INFα-2a therapy in cirrhotic hepatitis B patients. The balance of Th1/Th2 subgroup cytokines were one of the important factors resulting in the normal ALT,changing HBeAg and the descent HBVDNA tites.
     结论T细胞亚群Th1/Th2细胞因子与慢性乙肝IN-Fα-2a抗病毒治疗后血清ALT复常及HBVDNA含量下降相关,Th1/Th2亚群细胞因子平衡是促进肝功能ALA恢复、HBeAg血清转换及HBVDNA含量下降的重要因素之一。
短句来源
更多       
  相似匹配句对
     Antiriral therapy of AIDS(a lecture)
     艾滋病抗病毒治疗
短句来源
     Antivirale Therapie des Zoster
     带状疱疹的抗病毒治疗
短句来源
     Imaging Of Brain Tumors after Therapy
     治疗脑瘤的影像学
短句来源
     The Treatment of Poststroke Depression
     卒中抑郁的治疗
短句来源
     timely pathological examination after transplntation could indicate the anti-virus treatment result.
     移植术及时的病理能够提示抗病毒治疗结果。
短句来源
查询“抗病毒治疗后”译词为用户自定义的双语例句

    我想查看译文中含有:的双语例句
例句
为了更好的帮助您理解掌握查询词或其译词在地道英语中的实际用法,我们为您准备了出自英文原文的大量英语例句,供您参考。
  antiviral therapy
Thus, early antiviral therapy and symptomatic treatment of complications can not only reduce mortality but also influence long-term sequelae.
      
Antiviral therapy of varicella-zoster virus infection in immunocompromised children - A prospective randomized study of aciclovi
      
A total of 301 patients were reported, of whom 214 received specific antiviral therapy with either ACV alone (n=179) or ACV plus β-IFN (n=35).
      
Failure of antiviral therapy in AIDS-associated cytomegalovirus cholangitis
      
The patient responded well to a second cycle of antiviral therapy but required a third treatment cycle due to renewed deterioration later on.
      
更多          


Auther determined the liver enaymogram and HBVM in four chronic hepatic diseases which were seldom found by route test for hepatic functions. The enzymogram and HBVM with anti-viral treatment were also determined. The enzymogram was comprosed of six kinds of enzyme, which were more sensitive and specific, also easily determined. The result demonstrated that the determination of the enzymegram and HBVM was significant to diagnosis and treatment for chronic hepatic diseases, especially in non-active chronic hepatic...

Auther determined the liver enaymogram and HBVM in four chronic hepatic diseases which were seldom found by route test for hepatic functions. The enzymogram and HBVM with anti-viral treatment were also determined. The enzymogram was comprosed of six kinds of enzyme, which were more sensitive and specific, also easily determined. The result demonstrated that the determination of the enzymegram and HBVM was significant to diagnosis and treatment for chronic hepatic diseases, especially in non-active chronic hepatic disease, chronic HBsAg carrier and static liver cirrhosis.

作者用敏感性和特异性较高、操作简便的六种血清酶组成肝酶谱,并与HBVM(ELLSA法)联合检测,研究了用常规肝功能试验检出率较低的四种慢性肝病的检测结果,并用抗病毒治疗后二者的变化验证其变化规律,认为二者联合检测对慢性肝病,特别是非活动性肝病(NACH)、慢性HBsAg携带者与静止性肝硬化的诊断、治疗和预后都具有重要意义。

To evaluate whether thymus-derived peptide treatment can enhance inhibition of HCV replication after antiviral therapy with interferon a-2b combined with acyclovir.Methods: 46 patients with chronic hepalitis C were treated with interferon a-2b combined with acyclovir.After about eight months of treatment, 31 cases had their disappearance of serum HCV RNA.These 31 patients were divided into two groups.One was treated intramuscularly with thymus-derived peptide at a dose of 5 ~ 10mg twice a week for three months...

To evaluate whether thymus-derived peptide treatment can enhance inhibition of HCV replication after antiviral therapy with interferon a-2b combined with acyclovir.Methods: 46 patients with chronic hepalitis C were treated with interferon a-2b combined with acyclovir.After about eight months of treatment, 31 cases had their disappearance of serum HCV RNA.These 31 patients were divided into two groups.One was treated intramuscularly with thymus-derived peptide at a dose of 5 ~ 10mg twice a week for three months and the regimen were repeated once at an interval of 3~6mons; the other group was treated with conventional medicines such as vitamins and glucurolactone as control.All patients were detected for serum HCV RNA by polymerase chain reaction (PCR) once half a year.Results:66.67% (10/15) of patients in the group observed sustained with the loss of serum HCV RNA during follow-up of 30mons, while only 37.75%of cases with HCV RNA negative in the control group(P<0.05).We also found that most of relapse took place within the first year after end of antiviral treatment with interferon and acyclovir.Conclusions: The results suggest that after antiviral treatment, the use of immunoenhancement medicines may be an alternative method for persistent HCV suppression.

目的 观察干扰素联合阿昔洛韦治疗后胸腺肽再治疗对丙型肝炎病毒复制的影响,寻求减少HCV重新复制及提高抗病毒治疗中远期效果的方法。方法 31例经干扰素联合阿昔洛韦治疗血清HCV RNA阴转的慢性丙型肝炎患者,按序贯法随机分为两组:免疫强化组(简称强化组),采用胸腺肽间歇免疫强化治疗;对照组,采用普通保肝及对症治疗。结果 平均随访30个月后,两组血清HCV RNA阴转率分别为66.67%(10/15)和37.50%(6/16),差别显著(P<0.05)。无论强化组还是对照组,HCV RNA由阴转阳多数发生在抗病毒治疗后一年之内。讨论 这一结果提示,丙型肝炎抗病毒治疗取得近期效果后,随之的胸腺肽再治疗可能是维持病毒RNA阴转、提高抗病毒治疗中远期效果的有效手段之一。

Objective To investigate the significance of cytomegalovirus(CMV) PP65 antigen detection in antiviral treatment to prevent CMV disease after renal allografts. Methods CMV-PP65 antigen was checked by immunohistochemical methods at weekly intervals during the first 3 months after transplantation. Within 24 hours after the CMV-PP65 antigenemia test became positive, ganciclovir was administered at a dose of 1. 25 - 5 mg·kg - 1· d-1 intravenous drip. Results 42 of 100 recipients (42%) developed CMV antigenemia,...

Objective To investigate the significance of cytomegalovirus(CMV) PP65 antigen detection in antiviral treatment to prevent CMV disease after renal allografts. Methods CMV-PP65 antigen was checked by immunohistochemical methods at weekly intervals during the first 3 months after transplantation. Within 24 hours after the CMV-PP65 antigenemia test became positive, ganciclovir was administered at a dose of 1. 25 - 5 mg·kg - 1· d-1 intravenous drip. Results 42 of 100 recipients (42%) developed CMV antigenemia, and 1 of the other 58 cases (1. 7% ) with negative CMV antigenemia developed CMV disease. CMV antigen in all 42 cases(100%) disappeared after antiviral treatmenl, and 1 of them developed CMV disease. CMV antigenemia became negative on average day 24. 6 ±11. 3, and the average duration of antiviral therapy was(34. 2 ±7. 1 ) days. Conclusion Monitoring of CMV-PP65 antigenemia may be effective to guide the prophylactic antiviral therapy of CMV disease in renal allograft recipients, and CMV-PP65 antigen should be detected weekly within the first 3 months after renal transplantation.

目的 探讨巨细胞病毒(CMV)-PP65抗原检测在肾移植术后CMV病预防中的应用。方法采用免疫过氧化物酶法检测肾移植受者外周血白细胞CMV-PP65抗原,术后3个月内每周1次。结果100例肾移植受者中42例检出CMV-PP65抗原阳性,初次检出CMV-PP65抗原的平均时间为(23.6±16.7)d,平均抗原阳性细胞数为(7.8±5.3)个/5 ×104白细胞。抗病毒治疗中18例抗原阳性细胞数进一步升高,平均峰值为(16.40±3.1)个。58例抗原血症阴性的受者仅1例发生CMV病。42例CMV-PP65抗原血症阳性受者抗病毒治疗后抗原血症均阴转,1例发展为CMV病,平均阴转时间为(24. 6±11. 3) d,平均疗程为(34. 2±7.1) d。结论 CMV-PP65抗原监测可指导肾移植术后CMV病的预防性治疗。

 
<< 更多相关文摘    
图标索引 相关查询

 


 
CNKI小工具
在英文学术搜索中查有关抗病毒治疗后的内容
在知识搜索中查有关抗病毒治疗后的内容
在数字搜索中查有关抗病毒治疗后的内容
在概念知识元中查有关抗病毒治疗后的内容
在学术趋势中查有关抗病毒治疗后的内容
 
 

CNKI主页设CNKI翻译助手为主页 | 收藏CNKI翻译助手 | 广告服务 | 英文学术搜索
版权图标  2008 CNKI-中国知网
京ICP证040431号 互联网出版许可证 新出网证(京)字008号
北京市公安局海淀分局 备案号:110 1081725
版权图标 2008中国知网(cnki) 中国学术期刊(光盘版)电子杂志社